News

FILTER BY:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
GM looks like a ‘buy’ as long-term issues start to get resolved, says Mizuho’s Vijay RakeshGM looks like a ‘buy’ as long-term issues start to get resolved, says Mizuho’s Vijay Rakesh
News

GM looks like a ‘buy’ as long-term issues start to get resolved, says Mizuho’s Vijay Rakesh

December 5, 2023
Mizuho closes acquisition of M&A and restructuring advisory firm GreenhillMizuho closes acquisition of M&A and restructuring advisory firm Greenhill
Press Release

Mizuho closes acquisition of M&A and restructuring advisory firm Greenhill

December 1, 2023
Mizuho Americas wins five 2023 Markets Choice Women in Finance AwardsMizuho Americas wins five 2023 Markets Choice Women in Finance Awards
Press Release

Mizuho Americas wins five 2023 Markets Choice Women in Finance Awards

November 21, 2023
Mizuho's Moskowitz on Altman's OpenAI ousterMizuho's Moskowitz on Altman's OpenAI ouster
News

Mizuho's Moskowitz on Altman's OpenAI ouster

November 21, 2023
Jordan Klein on CNBC's Squawk on the Street (Starts at 1:41)Jordan Klein on CNBC's Squawk on the Street (Starts at 1:41)
News

Jordan Klein on CNBC's Squawk on the Street (Starts at 1:41)

November 21, 2023
Mizuho Americas announces increase in purse to $3 million for 2024 LPGA Mizuho Americas OpenMizuho Americas announces increase in purse to $3 million for 2024 LPGA Mizuho Americas Open
Press Release

Mizuho Americas announces increase in purse to $3 million for 2024 LPGA Mizuho Americas Open

November 20, 2023
China restrictions should have little impact on Nvidia’s near-term guidance, says Mizuho’s RakeshChina restrictions should have little impact on Nvidia’s near-term guidance, says Mizuho’s Rakesh
News

China restrictions should have little impact on Nvidia’s near-term guidance, says Mizuho’s Rakesh

November 14, 2023
How Novo Nordisk’s ‘select’ study results could shake up the obesity drug spaceHow Novo Nordisk’s ‘select’ study results could shake up the obesity drug space
News

How Novo Nordisk’s ‘select’ study results could shake up the obesity drug space

November 14, 2023
Novo and Eli Lilly stocks could go higher if they show even better data than we think: Mizuho’s HolzNovo and Eli Lilly stocks could go higher if they show even better data than we think: Mizuho’s Holz
News

Novo and Eli Lilly stocks could go higher if they show even better data than we think: Mizuho’s Holz

November 10, 2023
back-to-top-blue